Oleactiv® (Polyphenol-Rich Blend — Fytexia)

Evidence Level
Preliminary
1 Clinical Trial
3 Documented Benefits
1/5 Evidence Score

Oleactiv® is a polyphenol-rich ingredient from Fytexia, made from artichoke, olive and grape extracts and marketed for cardiovascular support. Its published research consists of a single manufacturer-funded 12-week experiment in 21 Golden Syrian hamsters, 7 of which received the blend. It has not been tested in a published human trial, so what it does in people is unknown.

Studied Dose No human dose has been established. In the published hamster study the blend was given by oral gavage at 55 mg per kg of body weight daily for 12 weeks; the authors converted this to a human equivalent of about 450 mg per day using a body-surface-area formula, a calculation rather than a dose that has been tested in people.
Active Compound A standardized blend of plant polyphenols from artichoke, olive and grape extracts. The batch analysed in the published research contained 16.1 g of identified phenolic compounds per 100 g, the largest contributors being oleuropein and hydroxytyrosol from olive, catechin and epicatechin from grape, and chlorogenic acid, cynarin and cynaroside from artichoke.

Benefits

Vascular protection

In hamsters fed a high-fat diet for 12 weeks, the blend was followed by 69% less fatty streak area in the aortic wall than in unsupplemented high-fat-fed animals. This is an animal result from a study funded by the ingredient's manufacturer; nothing comparable has been measured in people.

Cholesterol handling in animals

In the hamster study, supplemented animals showed 23% lower non-HDL cholesterol and 49% lower triglycerides than high-fat-fed controls, and their plasma accepted 17% more cholesterol from macrophages in culture. Total cholesterol was not significantly different (p = 0.058) and HDL cholesterol was unchanged. Nitric oxide, blood flow and blood pressure have not been measured for this blend in any species.

Polyphenol composition

The blend supplies polyphenols characteristic of artichoke, olive and grape - chlorogenic acid, cynarin, epicatechin and oleuropein among them. Markers of oxidative stress and of LDL oxidation were not measured in the published research on this blend, so its antioxidant effect in the body has not been demonstrated.

Mechanism of action

1

Cholesterol efflux

Plasma from supplemented hamsters accepted more cholesterol from cultured J774 macrophages than plasma from high-fat-fed controls (total efflux +17.3%, driven mainly by passive diffusion, +28.4%). The study's authors proposed this as the route by which arterial fat deposits were reduced. Oxidation and inflammation markers were not measured.

2

Lipid profile in the animal model

Twelve weeks of supplementation in high-fat-fed hamsters was followed by lower non-HDL cholesterol and triglycerides than in unsupplemented high-fat-fed animals, with no change in HDL cholesterol. Nitric oxide, vasodilation and vascular tone were not assessed.

Clinical trials

1
Animal study: Oleactiv® in high-fat-fed hamsters (not a human trial)
PubMed

Romain C et al. Nutrients 2018;10(10):1511. Preclinical animal study funded by Fytexia, the ingredient's manufacturer; two of the ten authors are Fytexia employees, and the paper's disclosure states that two of the academic laboratories involved were paid by Fytexia to perform and report the work.

21 male Golden Syrian hamsters (Mesocricetus auratus) in three groups of 7: standard diet, high-fat diet, or high-fat diet plus the blend at 55 mg/kg/day by oral gavage, over 12 weeks. No human participants.

Against the high-fat control group, supplemented hamsters had 69% less aortic fatty streak area, 23% lower non-HDL cholesterol, 49% lower triglycerides and 17% higher plasma cholesterol efflux capacity. Total cholesterol was not significantly different (p = 0.058) and HDL cholesterol was unchanged. These are results in animals; the blend has not been given to human participants in any published study.

Side effects and drug interactions

Common Potential side effects

No human safety or tolerability study of this blend has been published, so its side-effect profile in people is not known.
Concentrated plant polyphenol extracts can cause mild digestive upset in some people. Artichoke belongs to the daisy (Asteraceae) family, so people allergic to ragweed, chrysanthemums or marigolds may react to it, and artichoke extracts are traditionally avoided by anyone with bile duct obstruction or gallstones.
Discontinue if any unusual reaction occurs.

Important Drug interactions

Anticoagulant and antiplatelet drugs — no interaction study of this blend has been done; ask your doctor before combining.
Blood pressure and cholesterol medication — the blend has not been tested alongside these drugs, and it has not been shown to lower blood pressure in people.
Tell your doctor if you take cardiovascular medication.

Frequently asked questions about Oleactiv® (Polyphenol-Rich Blend — Fytexia)

What is Oleactiv?

Oleactiv® is a polyphenol-rich ingredient from Fytexia, made from artichoke, olive and grape extracts and marketed for cardiovascular support. Its published research consists of a single manufacturer-funded 12-week experiment in 21 Golden Syrian hamsters, 7 of which received the blend.

What is Oleactiv used for?

Oleactiv is researched primarily for Cardiovascular. In hamsters fed a high-fat diet for 12 weeks, the blend was followed by 69% less fatty streak area in the aortic wall than in unsupplemented high-fat-fed animals.

What is the recommended dosage of Oleactiv?

The clinically studied dose is No human dose has been established. In the published hamster study the blend was given by oral gavage at 55 mg per kg of body weight daily for 12 weeks; the authors converted this to a human equivalent of about 450 mg per day using a body-surface-area formula,… Always follow the product label and check with a healthcare provider for personal advice.

Is Oleactiv safe, and does it have side effects?

For most healthy adults, Oleactiv is well tolerated at studied doses. Reported effects can include: No human safety or tolerability study of this blend has been published, so its side-effect profile in people is not known. Concentrated plant polyphenol extracts can cause mild digestive upset in some people. It may also interact with some medications. Oleactiv is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does Oleactiv interact with any medications?

Possible interactions include: Anticoagulant and antiplatelet drugs — no interaction study of this blend has been done; ask your doctor before combining. Blood pressure and cholesterol medication — the blend has not been tested alongside these drugs, and it has not been shown to lower blood pressure in people. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for Oleactiv?

NutraSmarts rates the evidence for Oleactiv as Preliminary (1 out of 5). It is backed by 1 clinical trial and 3 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(3 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Romain C, Piemontese A, Battista S, et al. Anti-Atherosclerotic Effect of a Polyphenol-Rich Ingredient, Oleactiv®, in a Hypercholesterolemia-Induced Golden Syrian Hamster Model. Nutrients. 2018;10(10):1511..PubMedUsed to support: In 21 male Golden Syrian hamsters (7 per group), 12 weeks of the blend at 55 mg/kg/day by oral gavage alongside a high-fat diet was followed by 69% less aortic fatty streak area, 23% lower non-HDL cholesterol, 49% lower triglycerides and 17% higher plasma cholesterol efflux capacity than the high-fat control group; total cholesterol was not significantly changed (p = 0.058) and HDL cholesterol was unchanged. An animal study, funded by the ingredient's manufacturer, with no human participants.
  2. Ruano J, Lopez-Miranda J, Fuentes F, Moreno JA, Bellido C, Perez-Martinez P, Lozano A, Gomez P, Jimenez Y, Perez Jimenez F Phenolic content of virgin olive oil improves ischemic reactive hyperemia in hypercholesterolemic patients. Journal of the American College of Cardiology. 2005;46(10):1864-1868..PubMedUsed to support: In 21 adults with high cholesterol given two breakfasts in random order, the meal made with high-phenolic olive oil (400 ppm) was followed by better ischemic reactive hyperemia, higher nitrate/nitrite levels and smaller rises in lipid peroxides than the same oil with its phenolics reduced to 80 ppm. This was a single postprandial test using olive oil as a food, not a supplement, and it does not show that the artichoke-olive-grape blend affects endothelial function in people.
  3. Sahebkar A, Pirro M, Banach M, Mikhailidis DP, Atkin SL, Cicero AFG Lipid-lowering activity of artichoke extracts: A systematic review and meta-analysis. Critical Reviews in Food Science and Nutrition. 2018;58(15):2549-2556..PubMedUsed to support: Pooling 9 randomised trials in 702 adults, artichoke extract supplementation was followed by lower total cholesterol (-17.6 mg/dL, 95% CI -22.0 to -13.3), LDL cholesterol (-14.9 mg/dL, 95% CI -20.4 to -9.5) and triglycerides (-9.2 mg/dL, 95% CI -16.2 to -2.1), with no change in HDL cholesterol. These trials used artichoke leaf extracts on their own, at their own doses, not the artichoke-olive-grape blend described on this page.